Sepsis

Infectious Disease·MeSH: Sepsis

13 drugs in development·12 companies·16 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
nu.q nets	VOLITIONRX LTD (VNRX)
quelimmune	SeaStar Medical Holding Corporation (ICU)
s1 panel assay	NANOMIX CORP (BTHI)

Phase 2(6)

Drug	Company
allocetra-ots	Enlivex Ltd. (ENLV)
azd4144	ASTRAZENECA PLC (AZN)
regn7544	REGENERON PHARMACEUTICALS, INC. (REGN)
tin816	Novartis AG (NVS)
tin816 70 mg lyophilisate	NOVARTIS AG (NVSEF)
tin816 70 mg lyophilisate	Novartis AG (NVS)

Phase 1(1)

Drug	Company
nogapendekin alfa inbakicept	ImmunityBio, Inc. (IBRX)

Preclinical(3)

Drug	Company
man-11	Q BioMed Inc. (QBIO)
tellurium based compounds	Qrons Inc. (QRON)
zadaxin	SCICLONE PHARMACEUTICALS INC (SCLN)

BioSniper tracks 13 drugs in development for Sepsis across 12 companies.

There are 16 clinical trials targeting Sepsis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.